A A+ A A A

CBmed ABOUT

CBmed, an Austrian funded competence center, links excellent research infrastructure, scientific expertise, medical knowledge, national and international industry partners for systematic medical biomarker research.

CBmed brings together scientific experts with leading pharmaceutical, diagnostic, medical-technology and IT industry partners. In addition, CBmed has a strong network in the area of Biobanking including the largest Biobank in Europe, Biobank Graz, and the European Biobanking network BBMRI-ERIC. CBmed research projects will identify new biomarkers, validate potential biomarkers and conduct translational biomarker research for products to be used in clinical practice.

CBmed will develop easily applicable, targeted, minimally invasive biomarkers for better diagnosis, better therapy monitoring and a more personalized treatment of patients.

Download our USPs here.

A company presentation is available for download here.

See our new brochure here!

 

CBmed

  • identifies new biomarkers,
  • validates potential biomarkers and
  • conducts translational biomarker research

Research projects

CBmed Projects aim to develop easily applicable, targeted, minimally invasive biomarkers for better diagnosis, better therapy monitoring and a more personalized treatment of patients.

MORE ABOUT ALL PROJECTS AND PARTNERS

CBmed CEOs

Univ.-Prof. Dr. Thomas Pieber
CSO
thomas.pieber@cbmed.at

Ing. Robert Fasching
CFO
robert.fasching@cbmed.at

Our Vision

Our vision is to become the world's most recognized center for biomarker research in personalized medicine by 2030.

This will be achieved by integrating cutting-edge technologies with international and interdisciplinary expertise in the fields of cancer, metabolism and inflammation.

Together with our scientific and industry partners, we will develop solutions and products for patient care and cure.

 

CBmed Headquarter: 

 

  • Chief Scientific Officer: M.D. Thomas Pieber
  • Chief Financial Officer: Ing. Robert Fasching
  • Scientific Leader Area 1 Data &Technologies:
    Wolfgang Wadsak, PhD 
  • Scientific Leader Area 2 Cancer: M.D. Armin Gerger 
  • Scientific Leader Area 3 Metabolism & Inflammation: M.D. Harald Sourij
  • Team HQ Assistance: Mag. Julia Mühl
  • Director Business Development: Mag. Thomas Weber
  • R&D Global Footprint: M.D. Harald Sourij
  • Scientific Affairs: Selma Mautner, PhD
  • CBmed Coordinator Vienna: Wolfgang Wadsak, PhD
  • Human Resources, Finance & Controlling: Petra Majcen
  • Controlling: Mag. (FH) Elke Pacher
  • Purchasing and Project Management: Isabell Dolznig, MSc
  • EFQM Coordinator: Nina Krisper, MSc
  • IT Responsible: Christian Peitler